title: TOSCA - first international registry to address knowledge gaps in the natural history and management of tuberous sclerosis complex.
abstract: BACKGROUND
  Tuberous sclerosis complex (TSC) is a rare, multisystem, genetic disorder with an estimated prevalence between 1/6800 and 1/15000. Although recent years have seen huge progress in understanding the pathophysiology and in the management of TSC, several questions remain unanswered. A disease registry could be an effective tool to gain more insights into TSC and thus help in the development of improved management strategies.
  
  
  METHODS
  TuberOus SClerosis registry to increase disease Awareness (TOSCA) is a multicentre, international disease registry to assess manifestations, interventions, and outcomes in patients with TSC. Patients of any age diagnosed with TSC, having a documented visit for TSC within the preceding 12 months, or newly diagnosed individuals are eligible. Objectives include mapping the course of TSC manifestations and their effects on prognosis, identifying patients with rare symptoms and co-morbidities, recording interventions and their outcomes, contributing to creation of an evidence-base for disease assessment and therapy, informing further research on TSC, and evaluating the quality of life of patients with TSC. The registry includes a 'core' section and subsections or 'petals'. The 'core' section is designed to record general information on patients' background collected at baseline and updated annually. Subsections will be developed over time to record additional data related to specific disease manifestations and will be updated annually. The registry aimed to enrol approximately 2000 patients from about 250 sites in 31 countries. The initial enrolment period was of 24 months. A follow-up observation period of up to 5 years is planned.
  
  
  RESULTS
  A pre-planned administrative analysis of 'core' data from the first 100 patients was performed to evaluate the feasibility of the registry. Results showed a high degree of accuracy of the data collection procedure. Annual interim analyses are scheduled. Results of first interim analysis will be presented subsequent to data availability in 2014.
  
  
  CONCLUSIONS
  The results of TOSCA will assist in filling the gaps in understanding the natural history of TSC and help in planning better management and surveillance strategies. This large-scale international registry to study TSC could serve as a model to encourage planning of similar registries for other rare diseases.
authors.affiliation: Sussex Kidney Unit, Royal Sussex County Hospital, Eastern Road, Brighton, BN2 5BE, UK. chris.kingswood@bsuh.nhs.uk.
authors.forename: John C
authors.initials: JC
authors.lastname: Kingswood
authors.affiliation: IRCCS AUO San Martino IST-Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy. paolo.bruzzi@istge.it.
authors.forename: Paolo
authors.initials: P
authors.lastname: Bruzzi
authors.affiliation: Tor Vergata University Hospital, Rome, Italy. curatolo@uniroma2.it.
authors.forename: Paolo
authors.initials: P
authors.lastname: Curatolo
authors.affiliation: Division of Child and Adolescent Psychiatry, University of Cape Town, Cape Town, South Africa. petrus.devries@uct.ac.za.
authors.forename: Petrus J
authors.initials: PJ
authors.lastname: de Vries
authors.affiliation: Associazione Sclerosi Tuberosa ONLUS, Milan, Italy. lacarloski@gmail.com.|European Tuberous Sclerosis Complex Association, In den Birken, 30, 45711, Dattein, Germany. lacarloski@gmail.com.
authors.forename: Carla
authors.initials: C
authors.lastname: Fladrowski
authors.affiliation: Vivantes-Klinikum Neukölln, Berlin, Germany. Christoph.Hertzberg@vivantes.de.
authors.forename: Christoph
authors.initials: C
authors.lastname: Hertzberg
authors.affiliation: UZ Brussel VUB, Brussels, Belgium. Anna.Jansen@uzbrussel.be.
authors.forename: Anna C
authors.initials: AC
authors.lastname: Jansen
authors.affiliation: The Children's Memorial Health Institute of Warsaw, Warsaw, Poland. sergiusz.jozwiak@gmail.com.
authors.forename: Sergiusz
authors.initials: S
authors.lastname: Jozwiak
authors.affiliation: Hospital Necker Enfants Malades, Paris, France. rimanabbout@yahoo.com.
authors.forename: Rima
authors.initials: R
authors.lastname: Nabbout
authors.affiliation: Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany. Matthias.Sauter@med.uni-muenchen.de.
authors.forename: Matthias
authors.initials: M
authors.lastname: Sauter
authors.affiliation: Hôpital Nord, Saint Etienne, France. renaud.touraine@chu-st-etienne.fr.
authors.forename: Renaud
authors.initials: R
authors.lastname: Touraine
authors.affiliation: Institute of Child Health, University College London, London, UK. f.o'callaghan@ucl.ac.uk.
authors.forename: Finbar
authors.initials: F
authors.lastname: O'Callaghan
authors.affiliation: University Medical Center, Utrecht, Netherlands. B.Zonnenberg@umcutrecht.nl.
authors.forename: Bernard
authors.initials: B
authors.lastname: Zonnenberg
authors.affiliation: Novartis Farma S.p.A., Origgio, Italy. stefania.crippa@novartis.com.
authors.forename: Stefania
authors.initials: S
authors.lastname: Crippa
authors.affiliation: Novartis Farma S.p.A., Origgio, Italy. silvia.comis@novartis.com.
authors.forename: Silvia
authors.initials: S
authors.lastname: Comis
authors.affiliation: Association Sclérose Tubéreuse de Bourneville, Gradignan, France. gba.astb@gmail.com.
authors.forename: Guillaume Beaure
authors.initials: GB
authors.lastname: d'Augères
authors.affiliation: Moscow Institute of Pediatrics and Pediatric Surgery, Moscow, Russian Federation. ebelousova@inbox.ru.
authors.forename: Elena
authors.initials: E
authors.lastname: Belousova
authors.affiliation: TSA Tuberous Sclerosis Association, Nottingham, UK. thomase.carter@virgin.net.
authors.forename: Tom
authors.initials: T
authors.lastname: Carter
authors.affiliation: Hôpital Louis Pradel, Claude Bernard University Lyon 1, Lyon, France. vincent.cottin@chu-lyon.fr.
authors.forename: Vincent
authors.initials: V
authors.lastname: Cottin
authors.affiliation: Karolinska University Hospital, Stockholm, Sweden. maria.dahlin@karolinska.se.
authors.forename: Maria
authors.initials: M
authors.lastname: Dahlin
authors.affiliation: Centro Hospitalar Lisboa Ocidental, Lisbon, Portugal. joseccferreira@sapo.pt.
authors.forename: José Carlos
authors.initials: JC
authors.lastname: Ferreira
authors.affiliation: Hospital Universitari Vall d'Hebron, Barcelona, Spain. amacaya@vhebron.net.
authors.forename: Alfons
authors.initials: A
authors.lastname: Macaya
authors.affiliation: SPS Pediatrična Klinika, Ljubljana, Slovenia. mirjanap.benedik@gmail.com.
authors.forename: Mirjana Perkovic
authors.initials: MP
authors.lastname: Benedik
authors.affiliation: Tallinn Children Hospital, Tallinn, Estonia. valentin.sander@lastehaigla.ee.
authors.forename: Valentin
authors.initials: V
authors.lastname: Sander
authors.affiliation: "St. Sophia" Children's Hospital, Athens, Greece. sotel@hol.gr.
authors.forename: Sotirios
authors.initials: S
authors.lastname: Youroukos
authors.affiliation: Novartis Farma S.p.A., Origgio, Italy. ramon.castellana@novartis.com.
authors.forename: Ramon
authors.initials: R
authors.lastname: Castellana
authors.affiliation: Novartis Pharma AG, Basel, Switzerland. bulent.ulker@novartis.com.
authors.forename: Bulent
authors.initials: B
authors.lastname: Ulker
authors.affiliation: Universitätsklinik für Kinder-und Jugendheilkunde, Vienna, Austria. martha.feucht@meduniwien.ac.at.
authors.forename: Martha
authors.initials: M
authors.lastname: Feucht
mesh_terms: D001364:Awareness; D015331:Cohort Studies; D019468:Disease Management; D005260:Female; D005500:Follow-Up Studies; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D038622:Internationality; D008297:Male; D012042:Registries; D014402:Tuberous Sclerosis / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*